Jefferies Financial Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Jefferies Financial Group’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35,000	Closed	-$1.39M	–	1974
2024 Q1	$1.39M	Sell	35,000 -65,152	-65%	-$1.92M	0.01%	706
2023 Q4	$1.91M	Buy	+100,152	New	+$1.39M	0.01%	731

Jefferies Financial Group's ALPN Position: Q2 2024 in Review

Jefferies Financial Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 35,000 shares — an estimated $1.39M sold.

Jefferies Financial Group first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $1.91M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Jefferies Financial Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Jefferies Financial Group sold 35,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.39M.
Jefferies Financial Group first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Jefferies Financial Group's Alpine Immune Sciences Inc position peaked at $1.91M in Q4 2023.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.